SMTL ID : 5hni.1 (1 other biounit)

CRYSTAL STRUCTURE OF CMET WT with compound 3

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.71 Å

Oligo State

monomer

Ligands

1 x 63B: methyl (6-{[6-(4-fluorophenyl)[1,2,4]triazolo[4,3-b]pyridazin-3-yl]sulfanyl}-1H-benzimidazol-2-yl)carbamate(Non-covalent)

63B.1: 17 residues within 4Å: Chain A: V.44, A.60, L.92, L.109, P.110, Y.111, M.112, K.113, G.115, D.116, R.160, N.161, M.163, A.173, D.174, A.178, Y.182 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:A.60, A:D.116, A:A.173, A:D.174, A:Y.182 Hydrogen bonds: A:Y.111, A:M.112, A:M.112, A:G.115, A:D.174 pi-Stacking: A:Y.182

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Ugolini, A. et al., Discovery and Pharmacokinetic and Pharmacological Properties of the Potent and Selective MET Kinase Inhibitor 1-{6-[6-(4-Fluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-ylsulfanyl]benzothiazol-2-yl}-3-(2-morpholin-4-ylethyl)urea (SAR125844). J.Med.Chem. (2016)

Release Date

2016-11-23

Peptides

Hepatocyte growth factor receptor: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
X

Hepatocyte growth factor receptor

Related Entries With Identical Sequence